Anonymous ID: 5bd40b Jan. 1, 2023, 10:21 a.m. No.18054182   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>4642

>>18053499 pb

>@CollinRugg Would you support a Flat tax of 15%?

 

let's be clear what you mean. you mean

15% FED

8% FICA (your company pays another 8%)

6% state (average most states)

3% state sales tax (6% average most states, assuming about half your money goes out that way)

6% house tax (median for most homeowners)

=38%

 

No, I would not "support" that.

 

If you mean 15% total, sure that would be great thank you.

Anonymous ID: 5bd40b Jan. 1, 2023, 10:30 a.m. No.18054236   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>4258

>>18054166

I've been attacked by random niggers on the street twice.

I was attacked by niggers in school.

Niggers are the scum of the earth

 

Every other race can be lived with. Only niggers cannot. And of course the one race that brings all the shit with them.

Anonymous ID: 5bd40b Jan. 1, 2023, 10:57 a.m. No.18054346   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

>>18054293

>texas-supreme-court-rules-against-father

 

see this is where the whole narrative breaks down.

it's all one system.

they try to lie and tell us it's only california and places like this.

 

it's always been a single system

 

Like 1964 with the silver out of the currency worldwide.

 

Many such cases. It's one fucking system

Anonymous ID: 5bd40b Jan. 1, 2023, 11:21 a.m. No.18054434   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>4461

>>18054400

>โ€ข By November 2020, the WHO said, "Do not use Remdesivir."

>

>โ€ข But instead, HHS added a 20% bonus on the entire hospital if they administered this liver and kidney-toxic drug.

 

Science has learned that both FDA's decision and the EU deal came about under unusual circumstances that gave the company important advantages. FDA never consulted a group of outside experts that it has at the ready to weigh in on complicated antiviral drug issues.

 

The European Union, meanwhile, decided to settle on the remdesivir pricing exactly 1 week before the disappointing Solidarity trial results came out. It was unaware of those results, although Gilead, having donated remdesivir to the trial, was informed of the data on 23 September and knew the trial was a bust.

 

"This is a very, very bad look for the FDA, and the dealings between Gilead and EU make it another layer of badness," says Eric Topol, a cardiologist at the Scripps Research Translational Institute who objected to remdesivir's FDA approval.

 

https://www.science.org/content/article/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug